124 related articles for article (PubMed ID: 33229118)
1. Multifaceted activity of polyciclic MDR revertant agents in drug-resistant leukemic cells: Role of the spacer.
Caciolla J; Picone G; Farruggia G; Valenti D; Rampa A; Malucelli E; Belluti F; Trezza A; Spiga O; Iotti S; Gobbi S; Cappadone C; Bisi A
Bioorg Chem; 2021 Jan; 106():104460. PubMed ID: 33229118
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
3. Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity.
Bisi A; Cappadone C; Rampa A; Farruggia G; Sargenti A; Belluti F; Di Martino RMC; Malucelli E; Meluzzi A; Iotti S; Gobbi S
Eur J Med Chem; 2017 Feb; 127():577-585. PubMed ID: 28109950
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
5. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
6. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
Ali W; Spengler G; Kincses A; Nové M; Battistelli C; Latacz G; Starek M; Dąbrowska M; Honkisz-Orzechowska E; Romanelli A; Rasile MM; Szymańska E; Jacob C; Zwergel C; Handzlik J
Eur J Med Chem; 2020 Aug; 200():112435. PubMed ID: 32505850
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological profile of new inhibitors of multidrug resistance associated proteins carrying a polycyclic scaffold.
Bisi A; Gobbi S; Merolle L; Farruggia G; Belluti F; Rampa A; Molnar J; Malucelli E; Cappadone C
Eur J Med Chem; 2015 Mar; 92():471-80. PubMed ID: 25596478
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
Hung CC; Chen CY; Wu YC; Huang CF; Huang YC; Chen YC; Chang CS
Eur J Med Chem; 2020 Sep; 201():112422. PubMed ID: 32569926
[TBL] [Abstract][Full Text] [Related]
9. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells.
Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404
[TBL] [Abstract][Full Text] [Related]
10. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance.
Yu L; Ren R; Li S; Zhang C; Chen C; Lv H; Zou Z; Pei X; Song Z; Zhang P; Wang H; Yang G
Eur J Med Chem; 2024 Jun; 272():116466. PubMed ID: 38704938
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
[TBL] [Abstract][Full Text] [Related]
12. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
Domínguez-Álvarez E; Gajdács M; Spengler G; Palop JA; Marć MA; Kieć-Kononowicz K; Amaral L; Molnár J; Jacob C; Handzlik J; Sanmartín C
Bioorg Med Chem Lett; 2016 Jun; 26(12):2821-2824. PubMed ID: 27156771
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers.
Teodori E; Contino M; Riganti C; Bartolucci G; Braconi L; Manetti D; Romanelli MN; Trezza A; Athanasios A; Spiga O; Perrone MG; Giampietro R; Gazzano E; Salerno M; Colabufo NA; Dei S
Eur J Med Chem; 2019 Nov; 182():111655. PubMed ID: 31494468
[TBL] [Abstract][Full Text] [Related]
14. Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analogues.
Nakagawa-Goto K; Chang PC; Lai CY; Hung HY; Chen TH; Wu PC; Zhu H; Sedykh A; Bastow KF; Lee KH
J Med Chem; 2010 Sep; 53(18):6699-705. PubMed ID: 20735140
[TBL] [Abstract][Full Text] [Related]
15. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy.
Coghi P; Ng JPL; Kadioglu O; Law BYK; Qiu AC; Saeed MEM; Chen X; Ip CK; Efferth T; Liu L; Wong VKW
Eur J Med Chem; 2021 Nov; 224():113676. PubMed ID: 34256125
[TBL] [Abstract][Full Text] [Related]
17. An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells.
Żesławska E; Kucwaj-Brysz K; Kincses A; Spengler G; Szymańska E; Czopek A; Marć MA; Kaczor A; Nitek W; Domínguez-Álvarez E; Latacz G; Kieć-Kononowicz K; Handzlik J
Bioorg Chem; 2021 Apr; 109():104735. PubMed ID: 33640632
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H
Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approach.
Azimian F; Hamzeh-Mivehroud M; Shahbazi Mojarrad J; Hemmati S; Dastmalchi S
Eur J Med Chem; 2020 Sep; 201():112461. PubMed ID: 32663641
[TBL] [Abstract][Full Text] [Related]
20. 3-Aryl-4-nitrobenzothiochromans
Micucci M; Viale M; Chiarini A; Spinelli D; Frosini M; Tavani C; Maccagno M; Bianchi L; Gangemi R; Budriesi R
Molecules; 2020 Feb; 25(5):. PubMed ID: 32120861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
